Nangmah emaw, i hriat tu emaw chuan hnute cancer natna zual tak i do a nih chuan, thu thar leh thil hmuhchhuah tharte hriat reng chu chakna tha tak a ni thei. Scientist leh doctor-te chuan he natna hi hrethiam zawk tur leh enkawlna thar, hlawk zawk zawng turin an bei fo thin . Chuvangin he beiseina thar hi eng nge a nih hi han thlir ila.
Damdawi pawm tharte
Damdawi thar eng emaw zat siam chhuah a ni tawh a, chungte chuan hnute cancer zual zel tan hlawhtlinna nasa tak an nei a ni. Chûng zînga ṭhenkhat chuan cancer cell-te ṭhanlenna controltu protein bikte chu target-in hna an thawk a ni.
A awlsam zawngin sawi ila, hnute cancer chi thenkhat chu taksa chhunga hormone awmte’n an lo thanglian theih nan a nghawng a ni. Hengte hi "hormone-receptor positive" cancer kan ti a. Tin, cancer cell thenkhatah chuan an chung lamah `HER2` tih protein an nei lo. Chungte chu `HER2` negative cancer an ti a. Hetiang cancer i neih chuan damdawi thar hi i tan chuan duhthlan tur tha tak a ni mai thei.
A hnuaia table-ah hian heng damdawi thar thenkhat hi han thlir ila.
| Damdawi chi hrang hrang | Ruihhlo Hming | A sawifiahna awlsam tak |
|---|---|---|
| CDK 4/6 Inhibitor te a awm bawk | Palbociclib (Ibrance) tih hi a awm a. Abemaciclib (Verzenio) chuan a rawn ti a. Ribociclib (Kisqali) a awm a. | Chungte chuan cancer cell inthen darh leh than dan a thunun a ni. A tlangpuiin hormone therapy nena pek dun an ni. Hei hian thla tam tak chhung chu cancer darh zelna a tikhawlo thei a ni. |
| Immunotherapy hmanga enkawl a ni | Sacituzumab govitecan (IMMU-132) hmanga tihdam theih a ni. | He damdawi hian cancer cell chunglama protein `Trop-2` an tih chu a target a ni. A bik takin enkawlna dang pahnih tal dawng tawhte tan a tha hle. |
A pawimawh ber chu heng damdawi te hi i tan a tha em tih te, i dawn dan tur te, a side effects te chu i doctor nen zalen taka inbiakna neih hi a ni.
Beiseina thar zirchianna stage-a la awm
Tuna damdawi pawmpui tawh bakah hian damdawi beisei awm tak tak, zirchian mek a awm nual bawk. Chûngte chu hman tlanglawn la ni lo mah se, nakin lawkah chuan kan tân malsâwmna ropui tak a ni thei a ni.
PARP Inhibitors te hi a awm bawk
Heng damdawi te hian cancer cell te insiamthat theihna (DNA repair) te chu a tikhawlo a ni. A bik takin hnute cancer nena inzawm gene BRCA1 emaw BRCA2 emaw-a mutation nei tan an tangkai hle tih hmuhchhuah a ni.
Tyrosine Kinase tihkhawtlai a ni
Hengte hi cancer cells te tihpunna tura puitu enzymes block tu damdawi an ni bawk. HER2-positive cancer tan Lapatinib (Tykerb) hi pawm a ni tawh bawk. Damdawi dang, Neratinib chu zirchianna tharah chuan damlote chu chemotherapy hnua pek an nih chuan dam rei zawk turin a pui tih hmuhchhuah a ni.
HER2 therapies target tam zawk
Hnute cancer vei mi panga zinga pakhat velin HER2 an tih protein an nei tam lutuk a, hei hian hnute cancer cells te tihpunna kawngah a pui a ni. He protein hi target tu damdawi hi nitin an siam chhuak zel a ni. Entirnan, damdawi Margetuximab hian tumor tihtlem kawngah result duhawm tak a nei a, damdawi ONT-380 hian hnute cancer enkawlna kawngah beisei awm tak a nei a, side effects tlem zawk a nei bawk.
Immunotherapy dangte pawh a awm bawk
Heng damdawi te hian cancer dona atana kan taksa chakna (immune system) tichakin hna a thawk a ni. Damdawi `Pembrolizumab` hian clinical trial-ah result duhawm tak a nei a, a bik takin hnute cancer chi hrang hrang `Triple-Negative`, a na zawk enkawlna atan a ni.
Cancer a darh dan hriatthiamna thar
Heng damdawi tharte rual hian scientist-te chuan taksa pum puia cancer a darh dan (metastasis) chungchangah thil thar an hmuchhuak bawk. He hriatthiamna hi nakin lawka enkawlna atan a pawimawh hle.
Ngaihtuah teh, cancer hi sipai atanga sipai pakhatin a chhuahsan a, hmun thara camp a siam ang maiin a darh thin tih kan ngaihtuah thin. Chu chu cancer cell pakhat chauh thisen kaltlangin a kal a, taksa peng dang, thin emaw lung emaw ang chiah a kal tihna a ni.
Mahse, tunah chuan zirchianna hnuhnung ber chuan, amah chauh ni lovin, hei hi a hmuchhuak ta a niCancer cells te hi clusters -ah an che niin an sawi a , sipai pawl khata kal dun ang maiin.
He thil hmuhchhuah hi a pawimawh hle a, a chhan chu, cancer awm dan dik tak kan hriat hnuah chuan scientist-te tan chuan chutiang pawlte titawp thei tur targeted treatment tam zawk siam a awlsam tawh dawn a ni. Chu chu, pawl pakhat chetna tihtawp chu cell pakhat tihtawp ai chuan a hlawk zawk thei tihna a ni.
Engtin nge he zinkawngah hian i puih theih ang?
Heng thil thar hmuhchhuah te nen hian nang pawh hian eng emaw ti takin he indonaah hian thawhpui theihna hun remchang i nei mai thei.
A pawimawh ber chu doctor nen inbiakna neih hi a ni . "Kan ramah hian ka tana tha tur enkawlna thar emaw, clinical trial thar emaw a awm em?" Clinical trial hi damdawi thar mipui zahawmte hnena pek a nih hmain a that leh him loh enfiahna, uluk taka enfiah a ni.
I doctor chuan chutiang trial-a telna hlawkna, hlauhawmna leh beisei turte chu a sawifiah thei ang. Thutlukna siam hmain doctor rawn hmasa phawt a pawimawh.
Tin, cancer vei tan support group te pawh en bawk ang che. Emotional support leh information thar an pe thei che a ni. He zinkawngah hian nangmah chauh i ni lo tih hre reng ang che.
Take-Home Thuchah a ni
- Tunah chuan hnute cancer natna zual zel tan damdawi thar leh hlawk zawk (CDK 4/6 inhibitors, immunotherapy) hman theih a ni tawh. Hengte hian cancer darh zel dan tur a thunun thei a ni.
- Science hi nitin hma a sawn zel a. Cancer hi cell pakhat angin ni lovin, pawl hrang hrangah a darh tih hmuhchhuah a nih avangin nakin lawka enkawl dan tur kawng thar a hawng ta a ni.
- I doctor nen hian i tana tha tur enkawlna thar ber ber leh clinical trial chungchang sawi fo thin ang che. Internet-a i thil hmuh zawng zawng hi ring suh, damdawi lam thurawn dik tak la rawh.
- He indona hi a harsa a, mahse nangmah chauh i ni lo. Khawvel hmun hrang hranga scientist leh doctor te hian nangmah ang damlote tanpui nan thil thar an zawng fo thin. Beiseina vawng reng rawh.











💬 Comments (0)
Comment a la awm lo. Hetah hian i comment hi a vawikhatna atan add rawh.
I comment kha add rawh